Antin JH - Search Results

1

Improved survival after acute graft-versus-host disease diagnosis in the modern era.

Khoury HJ, Wang T, Hemmer MT, Couriel D, Alousi A, Cutler C, Aljurf M, Antin JH, Ayas M, Battiwalla M, Cahn JY, Cairo M, Chen YB, Gale RP, Hashmi S, Hayashi RJ, Jagasia M, Juckett M, Kamble RT, Kharfan-Dabaja M, Litzow M, Majhail N, Miller A, Nishihori T, Qayed M, Schoemans H, Schouten HC, Socie G, Storek J, Verdonck L, Vij R, Wood WA, Yu L, Martino R, Carabasi M, Dandoy C, Gergis U, Hematti P, Solh M, Jamani K, Lehmann L, Savani B, Schultz KR, Wirk BM, Spellman S, Arora M, Pidala J. Khoury HJ, et al. Among authors: antin jh. Haematologica. 2017 May;102(5):958-966. doi: 10.3324/haematol.2016.156356. Epub 2017 Mar 16. Haematologica. 2017. PMID: 28302712 Free PMC article.

2

Cytokine dysregulation and acute graft-versus-host disease.

Antin JH, Ferrara JL. Antin JH, et al. Blood. 1992 Dec 15;80(12):2964-8. Blood. 1992. PMID: 1467511 Free article. Review.

3

Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.

Antin JH, Bierer BE, Smith BR, Ferrara J, Guinan EC, Sieff C, Golan DE, Macklis RM, Tarbell NJ, Lynch E, et al. Antin JH, et al. Blood. 1991 Oct 15;78(8):2139-49. Blood. 1991. PMID: 1717080 Free article.

4

Improved survival for patients with acute myelogenous leukemia.

Mitus AJ, Miller KB, Schenkein DP, Ryan HF, Parsons SK, Wheeler C, Antin JH. Mitus AJ, et al. Among authors: antin jh. J Clin Oncol. 1995 Mar;13(3):560-9. doi: 10.1200/JCO.1995.13.3.560. J Clin Oncol. 1995. PMID: 7884416 Clinical Trial.

5

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

Antin JH, Weinstein HJ, Guinan EC, McCarthy P, Bierer BE, Gilliland DG, Parsons SK, Ballen KK, Rimm IJ, Falzarano G, et al. Antin JH, et al. Blood. 1994 Aug 15;84(4):1342-8. Blood. 1994. PMID: 8049450 Free article.

6

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.

Porter DL, Roth MS, McGarigle C, Ferrara JL, Antin JH. Porter DL, et al. Among authors: antin jh. N Engl J Med. 1994 Jan 13;330(2):100-6. doi: 10.1056/NEJM199401133300204. N Engl J Med. 1994. PMID: 8259165 Free article.

7

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.

Fay JW, Wingard JR, Antin JH, Collins RH, Piñeiro LA, Blazar BR, Saral R, Bierer BE, Przepiorka D, Fitzsimmons WE, Maher RM, Weisdorf DJ. Fay JW, et al. Among authors: antin jh. Blood. 1996 Apr 15;87(8):3514-9. Blood. 1996. PMID: 8605372 Free article. Clinical Trial.

8

Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions.

Porter DL, Antin JH. Porter DL, et al. Among authors: antin jh. Cancer Treat Res. 1997;77:57-85. doi: 10.1007/978-1-4615-6349-5_3. Cancer Treat Res. 1997. PMID: 9071498 Review.

9

Treatment of chronic graft-versus-host disease with clofazimine.

Lee SJ, Wegner SA, McGarigle CJ, Bierer BE, Antin JH. Lee SJ, et al. Among authors: antin jh. Blood. 1997 Apr 1;89(7):2298-302. Blood. 1997. PMID: 9116272 Free article. Clinical Trial.

10

Relationship of Bcl-2 expression with apoptosis and proliferation in colonic graft versus host disease.

Kraus MD, Shahsafaei A, Antin J, Odze RD. Kraus MD, et al. Hum Pathol. 1998 Aug;29(8):869-75. doi: 10.1016/s0046-8177(98)90459-2. Hum Pathol. 1998. PMID: 9712431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters